Impact on sexual function of endoscopic enucleation versus transurethral resection of the prostate for lower urinary tract symptoms due to benign prostatic hyperplasia: A systematic review and meta‑analysis
Efficacy and safety of combination treatment with tadalafil and mirabegron for persistent storage symptoms despite tadalafil treatment in patients with benign prostatic hyperplasia
The hemodynamic interactions of the combined treatment with α-blockers and phosphodiesterase-5 inhibitors compared with α-blocker monotherapy: A systematic review and meta-analysis
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of overactive bladder associated with benign prostatic hyperplasia (CONTACT Study)
The prostatic urethral lift (Urolift) versus the convection water vapor ablation (Rezūm) for minimally invasive treatment of BPH: A comparison of improvements and durability in 3-year clinical outcomes
Correlation of alpha blocker with dementia in patients with benign prostate hyperplasia: A nationwide population-based study using the National Health Insurance Service database
Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: 12 month results of a clinical trial
Is the combination of alpha-blocker and phosphodiesterase-5 inhibitor better in improving the lower urinary tract symptoms and erectile dysfunction in comparison to monotherapy? A systematic review and meta-analysis
Diagnosing nocturnal polyuria (NP)-based on self-reported nocturnal void volume and fluid intake in clinical practice: Results from a real-world treatment survey in Europe and the USA
Nocturia due to nocturnal polyuria (NP) in women with overactive bladder (OAB) may be better managed by adding a low-dose desmopressin to tolterodine therapy